Boston Scientific settles DoJ stent recall probe for $74m
This article was originally published in Clinica
Executive Summary
Boston Scientific has agreed to pay $74m to settle a criminal investigation by the US Department of Justice into its voluntary recall in 1998 of a now obsolete stent system. The company has not admitted wrongdoing and no charges have been brought against it or any of its employees.